960401-34-7

Basic information

• Product Name: tert-butyl 3-(2-methoxy-4-nitrophenoxy)azetidine-1-carboxylate
• Synonyms: tert-butyl 3-(2-methoxy-4-nitrophenoxy)azetidine-1-carboxylate;1-Boc-3-(2-Methoxy-4-nitrophenoxy)azetidine
• CAS NO: 960401-34-7
• Molecular Formula: C₁₅H₂₀N₂O₆
• Molecular Weight: 324.3291
• Mol File: 960401-34-7.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: tert-butyl 3-(2-methoxy-4-nitrophenoxy)azetidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-(2-methoxy-4-nitrophenoxy)azetidine-1-carboxylate(960401-34-7)
• EPA Substance Registry System: tert-butyl 3-(2-methoxy-4-nitrophenoxy)azetidine-1-carboxylate(960401-34-7)

Safety Data

• Hazardous Substances Data: 960401-34-7(Hazardous Substances Data)

Usage

General Description

Tert-butyl 3-(2-methoxy-4-nitrophenoxy)azetidine-1-carboxylate is a chemical compound that belongs to the class of azetidine carboxylates. It is a white to off-white crystalline powder with a molecular formula of C14H19NO6 and a molecular weight of 293.3 g/mol. tert-butyl 3-(2-methoxy-4-nitrophenoxy)azetidine-1-carboxylate is commonly used in organic synthesis and pharmaceutical research due to its potential biological activities. It has been studied for its anti-inflammatory and analgesic properties, and has also been investigated for its potential use as a building block in the development of new drug candidates. Additionally, tert-butyl 3-(2-methoxy-4-nitrophenoxy)azetidine-1-carboxylate may have applications in the agricultural industry as a pesticide or crop protection agent.

Upstream product

• 454-16-0 1-fluoro-2-methoxy-4-nitrobenzene 
• 141699-55-0 tert-butyl 3-hydroxyazetidine-1-carboxylate 

Downstream Products

• 960401-42-7 3-(4-amino-2-methoxy-phenoxy)-azetidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

5- [4- (AZETIDIN-3-YL0XY) -PHENYL] -2-PHENYL-5H-THIAZ0L0 [5,4-C] PYRIDIN-4-0NE DERIVATIVES AND THEIR USE AS MCH RECEPTOR ANTAGONISTS

The present invention relates to a melanin concentrating hormone antagonist compound of formula I: wherein "-----" is absent or is optionally a bond; q is 1 or 2; R1 is independently selected from hydrogen, -C1-C2 alkyl, halo, hydroxy, -C1-C2 haloalkyl, -C1-C3 alkoxy, cyano, -O-C3-C4 cycloalkyl, and -OC1-C2 haloalkyl; R2 is selected from the group consisting of hydrogen, -C1-C3 alkyl, hydroxy, -C1-C3 alkoxy, cyano, -C1-C2 haloalkyl, -OC1-C2 haloalkyl, and halo; R3 is selected from the group consisting of hydrogen, -C1-C4 alkyl, -C2-C4 haloalkyl, -C2-C4 alkylOH, -C3-C6 cycloalkyl, -CH2C3-C6 cyxloalkyl, -C2-C4 alkyl-O-C1-C4 alkyl, -C(O)C1-C4 alkyl, -C(O)C1-C4 haloalkyl, -CH2-thiazole, phenyl, benzyl, tetrahydrothiopyranyl, and tetrahydropyranyl, wherein the cycloalkyl, tetrahydrothiopyranyl, tetrahydropyranyl and thiazolyl group is optionally substituted with one or two groups independently selected from the group consisting of halo, hydroxy, C1-C2 alkyl, and -C1-C2 haloalkyl; or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture thereof,, useful in the treating, preventing or ameliorating of symptoms associated with obesity and related diseases.